Disruption of Amyloid Precursor Protein Ubiquitination Selectively Increases Amyloid β (Aβ) 40 Levels Via Presenilin 2-mediated Cleavage
Overview
Authors
Affiliations
Amyloid plaques, a neuropathological hallmark of Alzheimer's disease, are largely composed of amyloid β (Aβ) peptide, derived from cleavage of amyloid precursor protein (APP) by β- and γ-secretases. The endosome is increasingly recognized as an important crossroad for APP and these secretases, with major implications for APP processing and amyloidogenesis. Among various post-translational modifications affecting APP accumulation, ubiquitination of cytodomain lysines may represent a key signal controlling APP endosomal sorting. Here, we show that substitution of APP C-terminal lysines with arginine disrupts APP ubiquitination and that an increase in the number of substituted lysines tends to increase APP metabolism. An APP mutant lacking all C-terminal lysines underwent the most pronounced increase in processing, leading to accumulation of both secreted and intracellular Aβ40. Artificial APP ubiquitination with rapalog-mediated proximity inducers reduced Aβ40 generation. A lack of APP C-terminal lysines caused APP redistribution from endosomal intraluminal vesicles (ILVs) to the endosomal limiting membrane, with a subsequent decrease in APP C-terminal fragment (CTF) content in secreted exosomes, but had minimal effects on APP lysosomal degradation. Both the increases in secreted and intracellular Aβ40 were abolished by depletion of presenilin 2 (PSEN2), recently shown to be enriched on the endosomal limiting membrane compared with PSEN1. Our findings demonstrate that ubiquitin can act as a signal at five cytodomain-located lysines for endosomal sorting of APP. They further suggest that disruption of APP endosomal sorting reduces its sequestration in ILVs and results in PSEN2-mediated processing of a larger pool of APP-CTF on the endosomal membrane.
Gu F, Boisjoli M, Naghavi M Nat Commun. 2023; 14(1):4227.
PMID: 37454116 PMC: 10349857. DOI: 10.1038/s41467-023-40000-x.
The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer's Disease.
Zhao Y, Gu Y, Zhang Q, Liu H, Liu Y J Clin Med. 2023; 12(5).
PMID: 36902671 PMC: 10003549. DOI: 10.3390/jcm12051883.
Guan P, Wang P Mol Neurobiol. 2023; 60(7):3617-3632.
PMID: 36877359 DOI: 10.1007/s12035-023-03277-z.
Mumtaz I, Ayaz M, Khan M, Manzoor U, Ganayee M, Bhat A Front Aging Neurosci. 2022; 14:977411.
PMID: 36158539 PMC: 9490081. DOI: 10.3389/fnagi.2022.977411.
Small but Mighty-Exosomes, Novel Intercellular Messengers in Neurodegeneration.
Kumari M, Anji A Biology (Basel). 2022; 11(3).
PMID: 35336787 PMC: 8945199. DOI: 10.3390/biology11030413.